Daptacel Articles
Pentacel gets FDA OK for pediatric use
5 February 2007
Aventis Pasteur launches Daptacel in USA
8 July 2002
US vaccine shortage addressed
24 June 2002
BioChem sells NAV stake to Baxter
25 November 1999
BioChem sells NAV stake to Baxter
19 November 1999
Chiron terminates marketing deal with NAV
28 October 1999
North American Vaccine Starts Sales of Certiva
30 November 1998
Certiva DTaP Vaccine Launched In USA
16 October 1998
NAV's Certiva Vaccine Approved In USA
6 August 1998
New Approvals Soon For DTaP-IPV Vaccine
25 June 1998
Certiva Nears Approval
11 May 1998
NAV Expects Certiva Approval By End-97
16 October 1997
NAV Combination Vaccine
26 June 1997
NAV's Certiva Vaccine "Safe And Effective"
2 December 1996
Showing 1-15 of 15 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
